Dr. Weltman's clinical and research interest is centered around optimizing medication therapy for patients with chronic kidney disease. She joined the faculty as a Research Assistant Professor in the Department of Pharmacy and Therapeutics in 2024. She is core faculty in the Center for Population Health Management in the Renal-Electrolyte Division at the University of Pittsburgh School of Medicine.
Dr. Weltman received her Doctor of Pharmacy degree from the University of Pittsburgh School of Pharmacy. Following graduation, she completed postdoctoral work at the University of Pittsburgh as a clinical research fellow. In this role, she was key in the implementation of the Kidney Coordinated HeAlth Management Partnership (Kidney CHAMP) study, which tested the effectiveness of a multifaceted electronic health record-based intervention on the delivery of evidence-based chronic kidney disease care. Dr. Weltman has used Kidney CHAMP data to explore medication-related outcomes in people with high-risk chronic kidney disease.
As a recipient of a Career Development Award from the National Institute of Diabetes and Digestive and Kidney Diseases, Dr. Weltman's current research is focused on discovering ways to improve nephrology-based prescribing of guideline-recommended medications, designing and building a pharmacist-led, population health management intervention, and testing the intervention in a pilot trial. Through this research, Dr. Weltman hopes to inform future effectiveness-implementation trials that target medication-related kidney and cardiovascular outcomes and develop new models of care that improve access to cardio-kidney protective medications.
Education & Training
PharmD
Clinical Pharmaceutical Sciences
2020 Top Poster Award, National Kidney Foundation Spring Clinical Meetings
Complete List of Published Work in MyBibliography:
https://www.ncbi.nlm.nih.gov/myncbi/melanie.weltman.1/bibliography/public/
Co-Presenters: Pooja Amarapurkar, MD, Michelle Turkovich, RN, Kaitlyn Lersch, PA-C
Multimodal Pharmacotherapy to Slow CKD: A New Paradigm.
Barriers to Optimal Pharmacotherapy in CKD. National Kidney Foundation Spring Clinical Meetings 2023, Austin, TX.
Co-Presenters: Calvin Meaney, PharmD, BCPS, Soo-Min Jang, PharmD, BCACP
"Opt-Out" Nephrology eConsults to Improve Care of High-risk Kidney Patients. Epic Expert Group Meetings (XGM) 2022, Clinical Advisory Council, Verona, WI.
Co-Presenter: Gary S. Fischer, MD
